Effects of tobacco smoke on IL-16 in CD8+ cells from human airways and blood: A key role for oxygen free radicals?

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 300, Issue 1, 2011, Pages

  Andersson, Anders ^a   Bossios, Apostolos ^b   Malmhäll, Carina ^b   Sjöstrand, Margareta ^b   Eldh, Maria ^b   Eldh, Britt Marie ^a   Glader, Pernilla ^a   Andersson, Bengt ^c   Qvarfordt, Ingemar ^a   Riise, Gerdt C ^a   Lindén, Anders ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Institute of Medicine   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Adaptive immunity; Chronic obstructive pulmonary disease; Glucocorticoid

Indexed keywords

BETA ADRENERGIC RECEPTOR; CASPASE 3 INHIBITOR; CD69 ANTIGEN; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 16; OXYGEN RADICAL; PHOSPHODIESTERASE; PROTEIN SYNTHESIS INHIBITOR; SCAVENGER; TOBACCO SMOKE;

ADULT; AGED; AIRWAY; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL FREE SYSTEM; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG LAVAGE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BRONCHOALVEOLAR LAVAGE FLUID; CD8-POSITIVE T-LYMPHOCYTES; FREE RADICAL SCAVENGERS; HUMANS; INTERLEUKIN-16; LECTINS, C-TYPE; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SMOKING;

EID: 78650631558     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00387.2009     Document Type: Article

References (43)

1. Andersson A, Qvarfordt I, Laan M, Sjostrand M, Malmhall C, Riise GC, Cardell LO, Lindén A. Impact of tobacco smoke on interleukin-16 protein in human airways, lymphoid tissue and T lymphocytes. Clin Exp Immunol 138: 75-82, 2004.
2. Aoki Y, Kao PN. Cyclosporin A-sensitive calcium signaling represses NFkappaB activation in human bronchial epithelial cells and enhances NFkappaB activation in Jurkat T-cells. Biochem Biophys Res Commun 234: 424-431, 1997.
3. Arima M, Plitt J, Stellato C, Bickel C, Motojima S, Makino S, Fukuda T, Schleimer RP. Expression of interleukin-16 by human epithelial cells. Inhibition by dexamethasone. Am J Respir Cell Mol Biol 21: 684-692, 1999. (Pubitemid 129502287)
4. 25+ regulatory T-lymphocyte response to tobacco smoking. Eur Respir J 31: 555-562, 2008.
5. Berman JS, Cruikshank WW, Center DM, Theodore AC, Beer DJ. Chemoattractant lymphokines specific for the helper/inducer T-lymphocyte subset. Cell Immunol 95: 105-112, 1985.
6. Campos MA, Wanner A. The rationale for pharmacologic therapy in stable chronic obstructive pulmonary disease. Am J Med Sci 329: 181-189, 2005. (Pubitemid 40529948)
7. Cantin AM, North SL, Hubbard RC, Crystal RG. Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol 63: 152-157, 1987.
8. Cruikshank WW, Kornfeld H, Center DM. Interleukin-16. J Leukoc Biol 67: 757-766, 2000.
9. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 329: 23-38, 2003.
10. De Bie, JJ, Jonker EH, Henricks PA, Hoevenaars J, Little FF, Cruikshank WW, Nijkamp FP, Van Oosterhout AJ. Exogenous interleukin- 16 inhibits antigen-induced airway hyper-reactivity, eosinophilia and Th2-type cytokine production in mice. Clin Exp Allergy 32: 1651-1658, 2002.
11. Dekhuijzen PN. Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease. Eur Respir J 23: 629-636, 2004.
12. Fournier M, Lebargy F, Le Roy Ladurie F, Lenormand E, Pariente R. Intraepithelial T-lymphocyte subsets in the airways of normal subjects and of patients with chronic bronchitis. Am Rev Respir Dis 140: 737-742, 1989.
13. Glader P, Eldh B, Bozinovski S, Andelid K, Sjostrand M, Malmhall C, Anderson GP, Riise GC, Qvarfordt I, Linden A. Impact of acute exposure to tobacco smoke on gelatinases in the bronchoalveolar space. Eur Respir J 32: 644-650, 2008.
14. Guerin JC, Leophonte P, Lebas FX, Liard F, Terrioux P, Boulanger P. Le stress oxydatif en pathologie bronchopulmonaire: apport del la N-acétyl-cystéine (NAC). Rev Pneumol Clin 61: 16-21, 2005.
15. Hernebring M, Brolen G, Aguilaniu H, Semb H, Nystrom T. Elimination of damaged proteins during differentiation of embryonic stem cells. Proc Natl Acad Sci USA 103: 7700-7705, 2006.
16. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350: 2645-2653, 2004.
17. 2- sensitivity and modulates BK channels in porcine tracheal smooth muscle. Br J Pharmacol 140: 939-947, 2003.
18. Kendig DM, Tarloff JB. Inactivation of lactate dehydrogenase by several chemicals: implications for in vitro toxicology studies. Toxicol In Vitro 21: 125-132, 2007.
19. Laan M, Linden A, Riise GC. IL-16 in the airways of lung allograft recipients with acute rejection or obliterative bronchiolitis. Clin Exp Immunol 133: 290-296, 2003.
20. Laan M, Qvarfordt I, Riise GC, Andersson BA, Larsson S, Linden A. Increased levels of interleukin-16 in the airways of tobacco smokers: relationship with peripheral blood T lymphocytes. Thorax 54: 911-916, 1999.
21. 8+ T cells in vitro. J Immunol 156: 310-315, 1996.
22. 8+ T cells is independent of transcription and translation. Evidence for constitutive protein synthesis and storage. J Immunol 155: 2902-2910, 1995.
23. MacNee W. Update in chronic obstructive pulmonary disease 2007. Am J Respir Crit Care Med 177: 820-829, 2008.
24. Mathy NL, Scheuer W, Lanzendorfer M, Honold K, Ambrosius D, Norley S, Kurth R. Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes. Immunology 100: 63-69, 2000.
25. McFadden C, Morgan R, Rahangdale S, Green D, Yamasaki H, Center D, Cruikshank W. Preferential migration of T regulatory cells induced by IL-16. J Immunol 179: 6439-6445, 2007.
26. Nuorti JP, Butler JC, Farley MM, Harrison LH, McGeer A, Kolczak MS, Breiman RF. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med 342: 681-689, 2000.
27. + T cells by IL-16 and IL-2. J Immunol 160: 2115-2120, 1998.
28. Prause O, Bossios A, Silverpil E, Ivanov S, Bozinovski S, Vlahos R, Sjöstrand M, Anderson GP, Lindén A. IL-17-producing T lymphocytes in lung tissue and in the bronchoalveolar space after exposure to endotoxin from Escherichia coli in vivo- effects of anti-inflammatory pharmacotherapy. Pulm Pharmacol Ther 22: 199-207, 2009.
29. Qvarfordt I, Riise GC, Andersson BA, Larsson S. Lower airway bacterial colonization in asymptomatic smokers and smokers with chronic bronchitis and recurrent exacerbations. Respir Med 94: 881-887, 2000.
30. Rauscher H. Medikamentöses Management der stabilen COPD. Wien Med Wochenschr 155: 95-100, 2005.
31. + lymphocytes. J Immunol 174: 2738-2745, 2005.
32. Shimonkevitz R, Northrop J, Harris L, Craun M, Bar-Or D. Interleukin- 16 expression in the peripheral blood and CD8 T lymphocytes after traumatic injury. J Trauma 58: 252-258, 2005.
33. + T-cell infiltration and improves paralysis and histopathology of relapsing EAE. J Neurosci Res 79: 680-693, 2005.
34. Smyth LJ, Starkey C, Vestbo J, Singh D. CD4-regulatory cells in COPD patients. Chest 132: 156-163, 2007.
35. Su Y, Han W, Giraldo C, De Li Y, Block ER. Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol 19: 819-825, 1998.
36. +-channel openers and other airway smooth muscle relaxants in isolated guinea-pig trachea. Eur J Pharmacol 326: 191-200, 1997.
37. Trosini-Desert V, Germaud P, Dautzenberg B. Exposition a la fumée du tabac et risque infectieux bactérien. Rev Mal Respir 21: 539-547, 2004.
38. Turato G, Zuin R, Miniati M, Baraldo S, Rea F, Beghe B, Monti S, Formichi B, Boschetto P, Harari S, Papi A, Maestrelli P, Fabbri LM, Saetta M. Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema. Am J Respir Crit Care Med 166: 105-110, 2002.
39. Wang S, Diao H, Guan Q, Cruikshank WW, Delovitch TL, Jevnikar AM, Du C. Decreased renal ischemia-reperfusion injury by IL-16 inactivation. Kidney Int 73: 318-326, 2008.
40. Wisnewski AV, Liu Q, Liu J, Redlich CA. Glutathione protects human airway proteins and epithelial cells from isocyanates. Clin Exp Allergy 35: 352-357, 2005.
41. + T cell responses in neonatal mice permit influenza-induced persistent pulmonary dysfunction. J Immunol 181: 3486-3494, 2008.
42. Zaks TZ, Chappell DB, Rosenberg SA, Restifo NP. Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: selective rescue by caspase inhibition. J Immunol 162: 3273-3279, 1999.
43. Zhang Y, Center DM, Wu DM, Cruikshank WW, Yuan J, Andrews DW, Kornfeld H. Processing and activation of pro-interleukin-16 by caspase-3. J Biol Chem 273: 1144-1149, 1998.